Q-omics provides the consensus-scored MIR520D profile across patient tissues and cancer cell-line models. MIR520D expression is associated with patient survival in 4 of 34 cancer types, with the highest sampling consensus in TGCT. Additionally, MIR520D RNA expression shows 5,957 significant pathway-activity associations, with the highest sampling consensus in STAD. Together, these results highlight TGCT, and STAD as cancer lineages where MIR520D shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.